| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
26,064
|
25,303
|
24,552
|
24,738
| | Cost of Revenue | 8,697 | 8,309 | 8,183 | 8,231 | | |
Gross Profit
|
17,367
|
16,994
|
16,369
|
16,507
| |
|
Operating Expenses |
|
Research Development | 3,405 | 2,906 | 2,936 | 2,954 |
|
Selling General and Administrative | 10,691 | 9,039 | 8,924 | 9,275 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 367 | 361 | 359 | 338 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
2,904
|
4,688
|
4,150
|
3,940
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (13) | 11 | 10 | (26) |
|
Earnings Before Interest And Taxes | 2,891 | 4,699 | 4,160 | 3,914 |
|
Interest Expense | 3 | 3 | 4 | 3 |
|
Income Before Tax | 2,888 | 4,696 | 4,156 | 3,911 |
|
Income Tax Expense | 763 | 1,645 | 1,590 | 1,528 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 2,125 | 3,051 | 2,566 | 2,383 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
2,125
|
3,051
|
2,566
|
2,383
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
2,125
|
3,051
|
2,566
|
2,383
|
|
0.06(0.40%) 1:55PM EDT - Nasdaq Real Time Price